logo
Plus   Neg
Share
Email

GSK Submits Daprodustat For Approval In Japan To Treat Renal Anaemia Due To CKD

GlaxoSmithKline plc (GSK.L,GSK) Wednesday announced that it has submitted a Japanese New Drug Application or JNDA to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat to treat patients with renal anaemia due to chronic kidney disease or CKD.

Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor or HIF-PHI. The company noted that HIF-PHIs are a new class of drug that trigger the body's adaptations to hypoxia and encourage the bone marrow to make more red blood cells, thereby benefitting patients with renal anaemia.

GSK said the JNDA for daprodustat is primarily based on positive data from the phase 3 programme conducted in Japan. The studies evaluated daprodustat for the treatment of anaemia in patients across the spectrum of CKD from stages 3-5.

Daprodustat is not approved as a treatment for renal anaemia or any other indication anywhere in the world.

If approved, daprodustat will be exclusively distributed in Japan by Kyowa Kirin Co., Ltd., following the strategic commercialisation deal announced in 2018.

GSK and Kyowa Kirin would jointly conduct launch activities, including engagement of healthcare professionals and commercial activities.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Millennials and Generation Zs, or people aged between 18 to 34 year, pay more for car repairs, according to a new survey. The average American spent $1,986 over the past five years on vehicle repairs and maintenance, according to a survey by Ally Financial conducted by Harris Poll. However, among... Gap Inc.'s (GPS) Old Navy brand announced plans to open 800 new stores as part of its upcoming split from its parent company. "We'll almost double our fleet to 2,000 stores in North America, predominantly in under-served small markets," Old Navy CEO Sonia Syngal said. The company said the plan was... Google has launched a new website called 'Recover Together,' a resource intended to help people recover from addiction or substance use disorder. The new service was launched by the search giant in recognition of the National Recovery Month in September. Google noted that more than 23 million Americans are recovering from addiction, while 20 million are still struggling to seek treatment.
Follow RTT